An audit examined pharmacy returns for 2022 and the first half of 2023. It identified high dispensing volumes and some patients receiving prescriptions from multiple prescribers, raising questions about oversight of the private medical route.[1]
Listed for context. No score change is recorded for Jersey here.
References
Checked. The date and the event were compared with a source that was read.